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1. Introduction 
Diabetic Foot Ulcers (DFUs) represent a frequent occurrence in the diabetic population and 
up to 15% of these subjects may be expected to develop a foot ulcer at least one time in 
his/her life1,2. DFUs cause personal, social and economic problems and are a serious risk 
factor for death3,4. These ulcers can be broadly classified as neuropathic, vascular5 or mixed, 
although the pathogenesis is much more complex. Biochemical6, hygienic7, structural 
deformity8,9, dynamic, pressure, skeletal, nutritional, socioeconomic factors, reduced 
antibacterial activity10,11,12, workplace influences, all concur to cause and maintain the lesion. 
A multicenter study attributed 63 percent of diabetic foot ulcers to the critical triad of 
peripheral sensory neuropathy, trauma, and deformity13. Most often healing requires the 
cooperation of many specialists, including surgeons, podiatrists, wound nurses and 
endocrinologists. In many cases, the definitive treatment demands minor or major surgery. 
While the treatment of vascular ulcers is straightforward and requires a bypass or a 
radiologic procedure if the damage to the limb is to be limited or cured, the treatment of 
neuropathic ulcers is much more complex. Most often relief of the abnormal pressure does 
not lead to the healing of the ulcer, rather these wounds are characteristically chronic, with 
alternating periods of partial improvement and relapse. Sometimes a superimposing 
infection worsens the clinical condition. These ulcers in general do not lead to major 
amputation of the limb but frequently cause considerable economic, social and 
psychological burden on the patient and his relatives.  
2. Etiology of the ulcer  
The distinctive characteristic of the diabetic ulcer is the tendency to become chronic. There 
are many definitions of “chronic”. The American Heritage Medical Dictionary and 
Stedman’s Medical Dictionary define chronic ulcers as a “longstanding ulcer with fibrous 
scar at its base. A thorough search through the literature does not give an exact definition of 
this term. Sometimes one can read of “ulcers lasting more than six months” but this ignores 
the wide array of biological backgrounds and the phenotypic presentations of these ulcers. 
We propose an equally subjective but more realistic definition: “an ulcer lasting more than one 
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could expect on the basis of previous experience in nondiabetic subjects”. The characteristic 
chronicity of the DFU was one of the bases for the diagnosis of diabetes before the 
introduction of the blood glucose assay. This idea penetrated the lore, and it is still possible 
to hear sentences like “I do not have diabetes, my ulcers heal quickly”.   
Chronic neuropathic ulcers usually occur as a result of a repeated trauma in the most 
exposed areas of the foot and ankle. However, not infrequently, may be the result of an 
acute trauma that is not recognized at the time of injury due to the relative pain 
insensitivity. The acute pathologic process is probably different and the outcome more 
favorable in the acute events versus the chronic ones. 
The neuropathic ulcers have many concurrent factors that come into play to initiate and 
sustain the ulcer process. Among the risk factors, the presence of peripheral neuropathy 
with the consequent reduced or absent pain sensation, of bone deformity that exposes the 
bone heads to an abnormal load, and of trauma are prevalent13. Some form of diabetic 
neuropathy is present in nearly 65 % of diabetic patients. Fifty percent of  these have a 
peripheral14 that causes the loss of protective sensation. The often associated autonomic 
nerve dysfunction decreases sweating and causes thin, dry, fissured skin15,16 that breaks 
easily. This autonomic dysfunction is one of the main causes of the severely damaged 
“Charcot foot”17,18. Trauma of any kind almost always has an initiating role. Acute wounds 
often are inadvertently self-inflicted during nail care or minor inadvertent injuries. Due to 
concomitant nerve damage, patients may not recognize or remember the trauma. The use of 
heaters to warm the feet or of overheated water to wash may cause burns or blisters that 
later develop into chronic wounds. The initiating factor in chronic pressure wounds most 
often is the repeated impact of an ill-fitting shoe on one area of the foot. Furthermore, 
diabetic patients have a peculiar rigidity of the joints that do not allow the foot to mold to 
the shoe or the floor19, thus creating an abnormal pressure and increasing the risk of injury. 
In many instances, calluses are an independent cause of injury, and is not uncommon to 
discover an ulcer beneath a callus.  
Diabetic neuropathies appear with such wide array of different clinical presentations and in 
so many different places, sometimes symmetrically, less frequently as mononeuropathies, 
that finding a common cause has till now been impossible.20,21 The most obvious culprit is 
hyperglycemia22, and at least at the beginning of the disease the normalization of the blood 
glucose can frequently revert to normal symptoms and signs of neuropathy.23,24 Chronic 
hyperglycemia plays an important role in the appearance of neuropathy. It is well known 
from the Diabetes Control and Complication Trial (DCCT) that strict control of blood 
glucose in newly diagnosed non complicated type 1 diabetics decreases the development of 
peripheral neuropathy in 60% of the cases over 5 years 25,26. However, the exclusive role of 
hyperglycemia has been challenged on the basis of the failure in some cases to achieve 
improvement of neuropathy with blood glucose control27,28 and other observations among 
which the increased incidence of this condition in prediabetes, 29,30,31 a state in which the 
blood glucose is still normal. Alternatively, a role of insulinopenia has been suggested.32,33 
Insulin receptors are present in the peripheral nervous system, and it is conceivable that any 
malfunction of insulin delivery34 may damage the function of neurons. There is also proof 
that in an experimental model of diabetes, a modest reduction of insulin levels even without 
an increase of the blood glucose levels can reduce the pain threshold.35,36 Thus it is possible 
that the insulin level required to regulate the nerve function is higher than that needed for 
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glucose control. Further, neuropathy can appear early also in type 2 diabetes37,38 where at 
least in the prediabetic stages, there is a compensatory hyperinsulinemia coupled with an 
increase in insulin resistance. This and the previous observation that a higher level of 
insulinemia is probably required for the regulation of the nervous than the glycemic system 
may point to a role of insulin resistance. In this case, the compensatory hyperinsulinemia 
could be present for many years and be effective to prevent the occurrence of overt diabetes, 
but not to prevent the nerve damage. Or, in turn, the insulin resistance could involve the 
nervous receptors to a higher degree than those involved in glucoregulation. It has also been 
shown that Insulin Growth Factor 1 (IGF1), a molecule that mimics many insulin 
effects,39,40,41 induces recovery of the nerve function in rats42. Taken together, these 
hypotheses fail to explain the pathogenesis of diabetic peripheral neuropathy and do not 
confirm an exclusive role of hyperglycemia. On the other hand, there is no doubt that 
hyperglycemia causes the microvascular damage frequently associated with the DFU. In a 
recent study the Authors found a graded association between HbA1C and carotid Intima 
Media Thickness (IMT) that is currently considered the best marker of progression of 
atherosclerosis.43 In this study LDL and HDL cholesterol, plasma triglycerides, and waist-to-
hip ratio were significantly associated with HbA1c after multivariable adjustment. Among 
other factors interfering with healing at the cellular level, the prevalence of infections in 
diabetics should not be overlooked. Chemotaxis, phagocytosis and all the bactericidal 
actions of neutrophils are impaired in uncontrolled diabetes4445. Also the formation of 
Advanced Glycation Endo Products (AGE), that  can bind to specific receptors on the 
leucocyte membrane (RAGE), may further impair the leucocyte antibacterial activity.46 Thus, 
at present we have not identified a distinctive cause nor we have a definite role for the co-
causal factors. One hypothesis put forward to explain the appearance and/or the 
progression of diabetic neuropathy is that impairment of synthesis of proteins may be the 
primary insult leading to the centripetal necrosis of the neuron 4748,49,50,51. Because this aspect 
is strictly connected with the topic of nutrition we will deal with it later in this chapter. This 
and many other hypotheses and their support were recently discussed in depth52 and are 
beyond the scope of his chapter 
3. The body composition of the subjects with an ulcer 
The body of a diabetic is different from the body of a person who has a normal blood 
glucose level. The well known changes at the molecular level, notably the accumulation of 
AGEs53 cause in time morphological changes of the tissues, with diffuse damage to the 
vascular walls, reduction of the body cell mass and lean body mass54, skin stiffness and 
prevalence of fat.  
What we broadly define lean body mass is in reality a composite of what is mostly the 
structural - protein component of the body including muscle, parenchymal organs, red 
blood cells, enzymes, mitochondria and the like,55 and has a critical role in maintaining the 
integrity of the body and permitting the survival. Although surprising there are very few 
studies of the body composition of type 2 diabetic subjects. To fill this gap we compared the 
body composition of 244 subjects with type 2 diabetes mellitus and demonstrated a 
reduction in the Body Cell Mass index (an index of the % mass of cells normalized for the 
actual height of the subject) in both sexes versus 266 non diabetic matched controls. 
Furthermore in 715 diabetics we also demonstrated that this reduction was proportional to 
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both the prevailing level of HbA1c in the last year and the duration of disease, although 
with the multiple regression analysis the former appears to account for most of the actual 
reduction52.  
There are many possible explanations for the protein/lean body mass loss: (1) the body of 
the diabetic is in a continuous catabolic state due to insulin deficiency and to the 
phenomenon of neoglucogenesis continuously turning aminoacids and fat into harmful 
glucose. This process lasts throughout the day in uncompensated diabetes56 without 
interruption at mealtime and is proportional to the blood glucose level57, in accordance with 
our observations. (2) Most diabetics have a persistent microalbuminuria, which represents 
another source of protein loss58 (3) the wound itself is a source of protein loss proportional 
to the size and depth of the lesion.59 (4) Because of the concomitant kidney damage these 
patients are frequently put on a protein reduced diet, on unsupported grounds60, thus 
aggravating their protein depletion. 
Furthermore the presence of the wound tends to change the metabolic environment towards 
catabolism: the secretion of proinflammatory cytokines in proportion to the size and the 
condition of the lesion increases the insulin resistance deranging glucose metabolism, and 
drives the body into a catabolic state. This phenomenon is particularly dangerous in 
diabetics who already have high circulating levels of cytokines secreted by the excess 
abdominal fat. The increased cortisol secretion as part of the stress response to the wound 
adds to the catabolism: less energy is derived from the fat mass, and the protein catabolism 
is increased. In turn the release of aminoacids drives the neoglucogenesis in the liver.  
To add further to this catabolic state, diabetic subjects have reduced levels of most anabolic 
hormones. Beyond the obvious absence or ineffectiveness of insulin on protein 
metabolism61,62,63 these subjects have a subnormal level of testosterone (low testosterone 
syndrome)64,65,66,67 with a characteristic hypogonadotropic hypogonadism64 responsible for 
the decreases the lean body mass. In view of all these events occurring together it is not 
surprising that most of these subjects are in a protein depleted state. As suggested before, it 
is possible that the failure of proteins synthesis involved in nerve functioning may result in 
impaired nerve regeneration and death.68,69,70,71  
 
Loss Catabolism  Reduced supply 
Kidney (microalbuminuria) 
Liver (neoglucogenesis) 
Ulcer (exudate) 
Low testosterone 
Low GH 
Fat derived cytokines 
Diet 
Protein losing enteropathy 
diarrhea 
Table 1. Common causes of protein malnutrition in the diabetic 
It is thus clear that decompensated diabetes is a catabolic condition further aggravated by 
the stress reaction and this creates a conflict with the ancestral mechanisms of survival of 
the body. A better comprehension of the wound healing process can be acquired through 
an analysis of these processes. The human body is programmed for survival and has a 
hierarchy of priorities for this aim72. The primary need is the conservation of the lean 
body mass defined as above as a composite of muscle, circulating enzymes, red blood 
cells, all the parenchymal organs, the immune organ and the water representing the 
metabolic and structural machinery of the body. Stated more simply the lean body mass is 
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all that is not fat. Any reduction of this mass poses a risk to survival. This compartment is 
continuously refilled with the proteins derived from the diet. The average energy need of 
a healthy young 70 kg person is 2500 cal / die obtained from the diet. Usually 20% of 
these (125 gr) derive from protein. However in times of abundance, when the lean body 
mass is replete, the organism deals with the wound as a nutritional priority and any 
aminoacid and protein supply acquired through the diet are diverted to the wound to 
promote the closure73. This diversion to the skin is a damage to the lean body mass 
because subtracts the aminoacids from the diet in proportion to the size and the depth of 
the ulcer. If the lesion is exceedingly large and deep also the protein content of the lean 
body mass is catabolized to aminoacids to support the repair of the skin. When more than 
15-20% 74,75,76 of the lean body mass is lost the survival mechanism changes radically its 
perspective and the true priority becomes the maintenance of this structure. Under these 
conditions the body uses all the hormonal and metabolic tools available to support the 
lean body mass, that includes antibodies and immune cells and almost nothing is left for 
the wound. The integrity of this lean mass is so critical that its reduction to <60% of the 
initial value usually leads to failure of the immune function and death due to 
pneumonitis77.  
 
Fig. 1. Main causes of protein malnutrition in diabetes 
We should envisage the body as  a sophisticated system with a central compartment (Lean 
Body Mass, LBM) supplying the periphery on demand. If a peripheral lesion (the ulcer) 
supervenes the central compartment supplies protein until a danger level of depletion is 
reached. The human body does not have a reservoir of spare proteins, and these have a low 
energetic yield. Thus a critical level of depletion is reached soon. This phenomenon is even 
more prominent in the protein depleted diabetics. In these subjects the central compartment 
of LBM is frequently already in borderline-low conditions and subtracts all the alimentary 
supply of proteins. In these conditions an ulcer will never heal. 
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In summary, in the presence of a chronic ulcer in a longstanding diabetic subject, we must 
always assume the existence of a certain degree of lean body mass (LBM) loss. The Body 
Bioimpedance analysis (BIA) is a widely used method for estimating the body composition 
and the presence of this condition. The technology is relatively simple, quick and 
noninvasive and evaluates the electrical impedance of body tissues, which provides an 
estimate of total body water (TBW). This value can be used to calculate the fat-free mass 
(FFM) and body fat (adiposity).In addition this technology can be used to evaluate the body cell 
mass (BCM). When the BCM is corrected for the actual height of the subject (Body Cell Mass 
Index, BCMI) gives a very accurate estimate of the total cellular mass and is a useful tool to 
assess the nutritional state, more so if a previous report is available for comparison to 
estimate the degree of damage. 78  
Diabetic foot ulcers tend to occur in the advanced stages of the disease. The usual saying 
that a characteristic of early diabetes is the slow healing of wounds dates back to a period 
when the diagnosis of the disease was delayed. Today a diagnostic delay only occurs in the 
poor and the underprivileged. In these subjects the catabolic state is usually well advanced 
and the skin is thin with widespread loss of the subcutaneous tissue, and a chronic 
nonhealing ulcer can be a presenting sign of diabetes. We demonstrated in 700 diabetics that 
at this stage the loss of the lean body mass is already advanced, and that the use of  re-
feeding solutions containing an increased percentage of proteins can help to recreate the 
lean body mass52 and the subcutaneous tissue79 
Clinical scenario Favorable Intermediate Worst 
Wound: 
Size 
Caloric / protein 
requirement 
 
-Small 
-low 
 
-medium 
-intermediate 
 
 
-large 
-high 
Lean body mass -healthy Healthy/  
slightly reduced 
-markedly reduced 
Nutrition Sufficient Sufficient/scant Scant 
Pathophysiology External supply 
redirected in 
percentage towards 
the ulcer 
External supply 
partitioned between 
the ulcer and the fat 
free mass 
 
External supply 
redirected towards 
the lean body mass 
Ulcer Heals rapidly Ulcer healing 
delayed /absent 
No ulcer healing 
Current treatments 
Since a single cause of the nonhealing diabetic foot ulcer has not been identified a variety 
of different products acting on, mimicking, or purportedly having magic qualities, have 
been introduced on the market without substantial proof of benefit, and often lacking 
rationale. 
Although frequently emphasized, the general condition of the patient, the strict control of 
his blood glucose and the general nutritional status are too frequently overlooked, mostly 
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in the general medical or surgical wards, where the attention is focused on the ulcer itself. 
The concern for the local factors and the commercial pressure of the pharmaceutical 
companies generated an incredible number of local treatments, including ointments, 
growth factors and the so called “advanced medications” containing a variety of metals 
and ions that should stimulate the reparative process. However the use of these 
substances did not demonstrate any substantial improvement in clinical studies. Although 
we do not think that these medications have a great role, we must acknowledge that 
proving the efficacy of these substances in healing ulcers with randomized controlled 
studies is a complicated and expensive task. It is evident that recruiting an adequate 
number of subjects with the same duration of disease, a similar degree of diabetic control, 
and an ulcer of the same characteristics for a randomized controlled trial is very difficult, 
and unless a substance has truly magical properties the statistical results will be open to 
discussion80,81,82 
What starts the cascade of problems in the diabetic is an alteration of glucose metabolism 
that in turn causes a series of metabolic derangements, and the dire consequences that 
follow. In a recent study the Authors found a significant prevalence of HbA1c >7% (53 
mmol/mol) and HDL < 50 mg/dl  in diabetic subjects with lower extremity disease 
versus those without.83 But if things are so simple, why is the normalization of blood 
glucose alone not able to induce tissue regrowth and ulcer healing? The answer is that a 
diabetic foot ulcer only appears after a long period of decompensated diabetes, when the 
nerves, the skin and all the supporting tissues and structures are already severely 
damaged or impaired and the simple correction of the causal abnormality is not enough. 
In this respect is worthwhile to mention the results of the Accord study casting doubt on 
the feasibility of intensive blood glucose control in diabetic patients with complications. 
In this study after an average of 3.5 years, 257 people in the intensive blood glucose 
lowering strategy group died, compared to 203 participants in the standard strategy 
group. This difference of 54 deaths resulted in a 22 percent increased death rate in the 
intensive group. Since the presence of a DFU is a complication these results have an 
important bearing on the treatment of these subjects.84 
Under normal circumstances the healing of an ulcer requires energy supplied by lipids 
and glucose. The role of glucose is probably the most complex because this molecule is 
part of the structural glycoproteins, of some enzymes85,86 and fuels the inflammatory 
cells87. Lipids for the energetic needs of healing can be obtained from the diet or from fat 
deposits. As happens for glucose, lipids have multiple functions: the most well known is 
energy storage, but these molecules also have signaling capacity and are structural 
components of the cell membrane. Both glucose and lipids must be available for the 
normal healing processes of the ulcers, but diabetics have a characteristic difficulty 
disposing of glucose inside the cells that can be only partially reversed with the available 
treatments. Proteins are structural components of the skin, but these subjects almost 
always have a degree of preexistent protein deficiency that must be taken into account 
when planning a diet. Estimating the degree of deficiency is the difficult part because the 
body composition is an individual characteristic and no “normal values” exist. The 
available tools to evaluate the degree of LBM and indirectly the degree of protein loss, like 
Bioimpedance Analysis and Skin Fold Thickness,  are only useful in the presence of 
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previous records of the same subject. The body weight loss, another simple and 
sequentially available measurement does not give any information on the body 
compartments and is thus of limited utility. However the presence of a nonhealing ulcer 
implies the loss of at least 20% of the LBM. When estimating the calorie-protein need of a 
diabetic the most reasonable option is to err on the excessive side.  
Although the role of nutrition is crucial and usually acknowledged, it is surprising how 
often is overlooked in practice. The most recent edition of the ADA book on the treatment of 
DFU88 does not even mention the general condition and the nutritional status of the patient 
among the aspects to evaluate. 
Our hypothesis is that the damage to the tissues is both preventable and at least partially 
reversible if the treatment is directed towards all the main causal factors. In other words, in 
our opinion if the vascular blood supply is normalized, the blood glucose level is kept under 
control, the abnormal pressure is reduced with adequate biophysical support and the 
texture of the skin is reconstituted there is absolutely no place for growth factors, colloids, 
metals or whatever else. The diabetic now has the same ability to heal as nondiabetics. The 
reconstitution of the skin requires the supply of proteins and other biological material that is 
usually reduced in the diabetic and must be supplied with adequate nutrition. The 
avoidance of relapses requires attention to postural and neurologic factors. 
4. Treatment 
The role of the nutritional condition of the patient with a DFU is crucial to the pathogenesis 
and treatment of the lesion, but infrequently recognized or treated. Accordingly, we think 
that the term “treatment of the DFU” is a misnomer and should be substituted with 
“treatment of the subject with a DFU”. We suggest a series of steps89: 
1. Whenever possible the nutritional condition should be assessed as accurately as 
possible, with Bio-Impedance Analysis, Skin Fold Thickness, Body Weight and Blood 
chemistry studies (protein electrophoresis, BUN, Hemogram). If previous values are 
available the change should be included as part of this assessment. 
2. The resting caloric requirement should be calculated as 20-25 kcal/kg body weight. This 
value  decreases  in the elderly. The value so obtained should be multiplied by 1.2-1.5 
according to the severity of the lesion.90 This figure should be increased if there is 
evidence of malnutrition. 
3. Add the caloric expenditure of activity. All these measurements can be obtained with 
the use of indirect calorimetry or with the recently introduced non-invasive tools worn 
at the arm that are worn over a longer period of time. The statistical elaboration of the 
Bio-Impedance Analysis can yield a reliable estimate of the Basal Metabolic Rate 
4. The value so obtained should be multiplied by a “stress factor” that varies from 1.2 for 
clean wounds, to 1.5 in the case of infected wounds 
All these calories should be replaced with an adequate diet, with no less that 20-22% protein 
given in at least three divided doses throughout the day. These values should be increased 
by 30-50% according to the co-morbidities of the subject. Paddon Jones suggests that non 
diabetic elders should have a minimum of 15 g of essential amino acids, equivalent to about 
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30 g of high-quality dietary protein at each meal.91Although there are no fast and hard rules 
this figure must be increased in the diabetic with a chronic wound. 
Another critical component is hydration92. We suggest to drink at least 2-3 lt of water per 
day. In addition to the maintenance of the circulation and the tissue exchange of 
metabolites, the water induced diuresis helps the body to get rid of the excess glucose. 
Some trace substances and vitamins are also absolutely needed for the healing process. In 
particular Vitamin C, E, Selenium and -carotene with strong antioxidant properties that 
antagonize the harmful oxygen free radicals (ROS) present in excess in the chronic wound93. 
Vitamin C is also needed for collagen formation.94 
The progression of the ulcer should be evaluated with inspection, with photographic 
records including a ruler close to the lesion, with the biochemical analytes useful to monitor 
the inflammation and the nutritional state (ESR, Hemogram, CRP, Albumin and Prealbumin 
levels), and the BIA. 
5. The role of supplements 
The body of the diabetic is in a general catabolic state and restituting the normal catabolism 
is a distinctive advantage for the treatment. According to this principle testosterone 
treatment has been instituted.95 We use transdermal testosterone supplement in testosterone 
deficient subjects with apparent reduction in healing time, although we did not conduct a 
systematic study. Other anabolic hormones have been used with variable results.96 We have 
a good experience with an oral nutritional supplement, a blend containing Argine, 
glutamine and -hydroxy- -methyl-butyrate (HMB). HMB is normally present in the 
muscle, is an active leucine metabolite and a potent stimulator of mTOR (Mammalian Target 
of Rapamycin), an intracellular protein controlling protein synthesis.97,98 Due to this 
anabolic property, the substance is widely used by the athletes worldwide, and to reverse 
the effects of aging.99 Glutamine also has a spectrum of positive effects100, notably 
stimulation of protein synthesis and support of immune function.101,102 and a positive effect 
on intestinal integrity.103 Its effectiveness in collagen formation has also been consistently 
proven.104 Arginine also has a positive effect on wound healing105, and stimulates immune 
function.106,107 Arginine also has a vasodilator action108 that was exploited for male erectile 
dysfunction before the introduction of the phosphodiesterase inhibitors. In our experience 
the use of this blend reduced to 1/3 the time to healing in a group of 12 diabetic patients 
while improving the lean body mass.109 We also found an unexpected reduction of 
microalbuminuria in 16 diabetic subjects under treatment with this blend, which might 
concur to explain the increase in lean body cell mass110  
It should be emphasized that the use of anabolic substances or blends is no substitute for an 
adequate nutrition with enough protein, calories, minerals, vitamins and iron that can be 
found in the normal Western diet. Therefore, the best nutritional approach to the diabetic 
patient is: (1) the evaluation of the degree of wasting of the lean body mass and of the 
degree of current needs; (2) institution of a diet supplying what is missing and what is 
currently required, supplemented with enough protein, and distributed in at least three 
meals per day. This diet should be integrated with vitamins, minerals and iron; (3) use of 
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anabolic agents or a blend of the three substances we used. Irrespective of which medical 
treatment will be used, the closure of a wound will be impossible unless these steps are 
followed. 
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